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The Unexpected Role of Calcium-Activated Potassium Channels:
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Background-—Multiple studies have shown that an NO-induced activation of vascular smooth muscle BK channels contributes to the
NO-evoked dilation inmany blood vessels. In vivo, NO is released continuously. NO attenuates vessel constrictions and, therefore, exerts
an anticontractile effect. It is unknown whether the anticontractile effect of continuously present NO is mediated by BK channels.
Methods and Results-—This study tested the hypothesis that BK channels mediate the vasodilatory effect of continuously present
NO. Experiments were performed on rat and mouse tail and rat saphenous arteries using isometric myography and FURA-2
fluorimetry. Continuously present NO donors, as well as endogenous NO, attenuated methoxamine-induced vasoconstrictions. This
effect was augmented in the presence of the BK channel blocker iberiotoxin. Moreover, the contractile effect of iberiotoxin was
reduced in the presence of NO donors. The effect of the NO donor sodium nitroprusside was abolished by an NO scavenger and by
a guanylyl cyclase inhibitor. In addition, the effect of sodium nitroprusside was reduced considerably by a protein kinase G
inhibitor, but was not altered by inhibition of H2S generation. Sodium nitroprusside attenuated the intracellular calcium
concentration response to methoxamine. Furthermore, sodium nitroprusside strongly reduced methoxamine-induced calcium
influx, which depends entirely on L-type calcium channels. It did not affect methoxamine-induced calcium release.
Conclusions-—In summary, this study demonstrates the following: (1) continuously present NO evokes a strong anticontractile
effect on rat and mouse arteries; (2) the iberiotoxin-induced augmentation of the effect of NO is associated with an NO-induced
reduction of the effect of iberiotoxin; and (3) NO evoked a reduction of calcium influx via L-type calcium channels. ( J Am Heart
Assoc. 2018;7:e007808. DOI: 10.1161/JAHA.117.007808.)
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C alcium-activated potassium channels of high conduc-tance (BK; Kca1.1) are expressed ubiquitously in smooth
muscle tissues, especially in vascular smooth muscle. The
activity of vascular smooth muscle BK channels is regulated
by a large number of intracellular signaling pathways.1,2 In the
vascular system, BK channels have served as a brake on
vasoconstriction induced by transmural pressure, as well as
by several contractile agonists. Furthermore, they are medi-
ators of vasodilation induced by several relaxing agonists.
NO is a powerful vasodilator and an antiproliferative and
anti-inflammatory agent. The vasodilatory effect of NO is
mediated mostly by soluble guanylyl cyclase, which produces
cGMP,3 activating PKG (protein kinase G). PKG, in turn,
phosphorylates several different proteins,4 particularly BK
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channels.5,6 Alternatively, NO has been reported to directly
modulate BK channels.7 Multiple studies have shown that an
NO-induced activation of vascular smooth muscle BK channels
contributes to the NO-evoked dilation in many blood vessels8–11
(additional studies listed and discussed by Tanaka et al12).
In vivo, the bloodstream is continually exerting shear stress
on the vessel wall, leading to a continuous release of NO. The
vessel wall is, therefore, constantly exposed to NO. NO then
attenuates vessel constrictions induced by, for example,
transmitters released from nerve endings or circulating
hormones: NO exerts an anticontractile effect. It is unknown
whether the anticontractile effect of continuously present NO is
also mediated by BK channels. This question may not seem
exciting in light of the overwhelming evidence demonstrating
that BK channels mediate vasodilation induced by NO (see
studies listed and discussed by Tanaka et al12). However, even
in these studies, reported findings have varied. Indeed, the BK
channel blockers charybdotoxin or iberiotoxin did not affect S-
nitroso-N-acetylpenicillamine–induced relaxation of guinea pig
aorta and carotid arteries,13 3-morpholino-sydnonimine–
induced hyperpolarization of rabbit mesenteric arteries,14
sodium nitroprusside (SNP)–induced hyperpolarization of
guinea pig carotid arteries,15 and 3-morpholino-sydnonimine–
induced relaxation of rabbit carotid arteries.16 Thus, a contri-
bution of the BK channel to the vasodilatory effect of NO cannot
be predicted clearly, even less so for the never studied
anticontractile effect of permanently present NO. Therefore,
this study tested the hypothesis that BK channels mediate the
vasodilatory effect of continuously present NO.
Methods
The data, analytic methods, and study materials will be made
available to other researchers for purposes of reproducing the
results or replicating the procedure. The authors declare that
all supporting data are available within the article (and its
online supplementary files).
Animals
This investigation conforms with the US Guide for the Care
and Use of Laboratory Animals (8th edition, National Academy
of Sciences, 2011) and institutional guidelines. A governmen-
tal committee on animal welfare granted approval for the use
of laboratory animals in this study. Male, 8 to 12 weeks old,
Wistar rats (n=267) and male, 6 to 10 weeks old, C57BL/6
mice (n=15) were obtained from Janvier (France). Male, 6 to
10 weeks old, BKb1-deficient mice (n=17) (targeted disrup-
tion of BK channel b1 locus: exon 1 deleted) were kindly
provided by Prof. Olaf Pongs (University Hamburg) and have
been described previously.17 The animals were provided with
food and water ad libitum and were housed under standard-
ized conditions in a room with a controlled temperature
(22°C) and a 12-hour light-dark cycle.
Vessel Preparation
The rats were euthanized under CO2 narcosis by decapitation,
and mice were euthanized under isoflurane narcosis by
decapitation. The tail and the lower extremity (limb) were
quickly removed and placed in an ice-cold physiological saline
solution of the following composition (in mmol/L): 145 NaCl,
4.5 KCl, 1.2 NaH2PO4, 0.1 CaCl2, 1.0 MgSO4, 0.025 EDTA,
and 5 HEPES (pH 7.4). The tail and saphenous arteries were
isolated by removing all surrounding tissues. Small vessel
rings (2 mm in length) were used for further experiments. The
rat tail artery was selected because we had characterized
vascular smooth muscle BK channel properties and regulation
previously.18,19 Although not being used in studies on BK
channels, the rat saphenous artery has been used intensively
in other projects and was, therefore, also chosen for the
present study.20,21
Isometric Mounting of Vessels
For the recording of isometric tension, isolated vessels were
mounted onto 2 stainless steel wires in a wire myograph
(model 610M; Danish Myotechnology, Denmark) filled with
physiological salt solution (PSS), consisting of (in mmol/L):
120 NaCl, 4.5 KCl, 1.2 NaH2PO4, 1.0 MgSO4, 1.6 CaCl2,
0.025 EDTA, 5.5 glucose, 26 NaHCO3, and 5 HEPES at pH 7.4
oxygenated with carbogen (95% O2 and 5% CO2) at 37°C. Data
acquisition and analysis were performed using Labchart
(ADInstruments). The vessels were stretched to their optimal
lumen diameter (90% of the diameter they would have at a
transmural pressure of 100 mm Hg22). Viability of the vessels
Clinical Perspective
What Is New?
• Continuously present NO evokes a strong anticontractile
effect on several arteries.
• This effect is limited by smooth muscle BK channels
because of an NO-induced reduction of calcium influx via L-
type calcium channels.
What Are the Clinical Implications?
• In several diseases, such as hypertension and diabetes
mellitus, an impaired BK channel function has been
observed.
• Previously, the latter was considered to lead to a reduced
NO-induced vasodilation.
• The new data propose that the opposite may be the case.
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was tested with the following: (1) methoxamine at 105 mol/
L to test smooth muscle cell function; and (2) acetylcholine at
105 mol/L after preconstriction with 106 mol/L methox-
amine to test endothelial cell function. In some experiments, a
solution containing 120 mmol/L KCl was used, which was
prepared on the basis of PSS by equimolar replacement of
NaCl. All vessel tension data were normalized to the tension
developed in response to 105 mol/L methoxamine, applied
after the viability test. In most cases, the vessel response of
interest was a cumulative concentration-response relationship
to methoxamine. Herein, the response of the vessel to a
particular concentration of methoxamine, except the lowest
one, was dependent on the response to the preceding
methoxamine concentration. To avoid dealing with interde-
pendent data during statistical analysis, the concentration-
response relationships were characterized by just 1 param-
eter: their area under the curve.
Functional Removal of the Endothelium
In all experiments, except the series testing the effect of
acetylcholine and carbachol, the endothelium of the vessels
was removed by mechanical disruption using a rat whisker.
Functional removal of the endothelium was considered
successful when acetylcholine-induced vasodilation was
absent during the viability test.
Experimental Protocol
Most experiments were performed using a standardized
protocol (Figure S1). Each vessel was assigned to a particular
experimental group: either the control group or 1 of the
treatment groups (eg, iberiotoxin, SNP, and iberiotoxin+SNP;
all experimental groups belonging to a particular experimental
series are thus determined by the corresponding figure
legend). After the viability test, all vessels were challenged
with increasing concentrations of methoxamine in the range
from 108 to 105 mol/L applied cumulatively in half-log
steps for predefined durations. Reliable comparisons of
vessel responses between groups required that the vessels
in these groups possess the same average initial contractility.
Therefore, the average concentration-response relationships
to methoxamine obtained directly after the viability test had
to be similar (Figure S1A). This was routinely tested in all
experimental series. In many experimental groups, vessels
were pretreated with the BK channel inhibitor iberiotoxin
after methoxamine washout. If this was the case, distilled
water, which is the solvent of iberiotoxin, was applied to a
control group at the same time. Afterwards, concentration-
response relationships to methoxamine were obtained again.
Reliable comparisons of vessel responses between groups
required that all vessels exposed to iberiotoxin possess the
same average contractility. Therefore, in this case, the
average concentration-response relationships to methoxam-
ine of the iberiotoxin groups also had to be similar
(Figure S1B). The same requirements were applied to all
vessels exposed to the solvent (Figure S1B). This was
routinely tested in all experimental series. Finally, after the
washout of all drugs applied, the substances to be studied
(eg, SNP) were added to the respective experimental groups,
and treatments (eg, iberiotoxin) were repeated. Then,
concentration-response relationships to methoxamine were
obtained again. The latter were used to evaluate the effects
studied and are presented in the figures. With this protocol,
only data obtained at the same time point during the
experiment are compared. Thus, time control experiments
were not required. Only NO donors showing a stable
relaxation over the time course of the experiment were used
(Figure S2).
The standardized protocol was not followed in experiments
in which the intracellular calcium concentration ([Ca2+]i) was
measured. These protocols are described either in the
following section or, because of their specific nature, as an
introduction to the corresponding results.
Determination of [Ca2+]i
Isolated vessels were mounted and a viability test performed,
as described in Isometric Mounting of Vessels, but in a 1-
chamber wire myograph (model 410A; Danish Myotechnology,
Denmark). After the viability test, vessels were loaded with
5 lmol/L FURA 2-AM at 37°C for 90 minutes. During
measurements, the dye was excited with light at 340 and
380 nm with use of a filter wheel and a xenon arc lamp. The
emission from the vessel was filtered at 520 nm with a long-
pass filter, detected by a photomultiplier, and sent to a
computer. There, the ratio of emission at the 2 excitation
wavelengths after subtraction of the background fluorescence
at the respective excitation wavelength was calculated
(F340/F380). Background fluorescence was determined from
the mounted vessel just before FURA 2 loading. The F340/
F380 ratio was used as a measure for the [Ca2+]i. Calibration
of the ratio in terms of absolute calcium concentrations was
not performed because of the numerous uncertainties related
to the binding properties of FURA 2 with [Ca2+]i in intact
vessel preparations. All data were normalized to the F340/
F380 ratio developed in response to 105 mol/L methoxam-
ine, applied after the viability test.
The loading state of the [Ca2+]i stores was determined by
bathing vessels in a solution containing 39103 mol/L EGTA
to eliminate calcium influx from the extracellular space and by
adding the pore-forming agent ionomycin at 105 mol/L. At
this concentration, ionomycin is known to permeabilize
membranes to calcium ions. This has 3 effects: (1) it induces
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calcium influx from the extracellular space, (2) it evokes
calcium release from intracellular stores and empties the
latter, and (3) it renders calcium pumps and transporters
ineffective.23
Drugs and Chemicals
Acetylcholine, b-cyano-L-alanine, caffeine, carbachol,
diethylenetriamine/NO, hydroxycobalamin, ionomycin,
methoxamine, rhodanese, sodium cyanide, SNP, and sodium
thiosulfate were obtained from Sigma. S-nitroso-N-acetylpe-
nicillamine and the salts for the solutions were from Merck.
Barium chloride was from Riedel de Haen. Iberiotoxin and
stromatoxin were purchased from Alomone Labs. Cyclopia-
zonic acid, diphenyl phosphine oxide-1, glibenclamide,
nimodipine, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, ryan-
odine, and XE991 were obtained from Tocris (UK). Rp-8-Br-
PET-cGMPS was purchased from Biolog, NG-nitro-L-arginine
was purchased from Alexis, and FURA 2-AM was purchased
from Life Technologies.
Statistical Analysis
All values are given as meanSEM. N is the number of
animals tested. Statistical analysis was performed using
GraphPadPrism 6.0. The statistical method used is provided
in the figure legends for each particular analysis. Indepen-
dent-sample t test, paired-sample t test, repeated-measures
ANOVA, and 2-way ANOVA were used. For ANOVA, the
interaction and/or the effect of the specific treatment was
analyzed. The data of the methoxamine concentration-
response relationships were obtained during cumulative
addition of methoxamine. They are, thus, interdependent.
To avoid this issue during statistical analysis, these
relationships were represented by a single parameter: their
area under the curve. P<0.05 was considered statistically
significant.
Results
Contribution of the BK Channel to the
Anticontractile Effect of NO
To study the anticontractile effect of NO, vasoconstrictor-
induced vessel responses were investigated in the absence
and presence of the NO donor, SNP. Vasoconstriction of rat
tail arteries was evoked by the selective a1-adrenoceptor
agonist, methoxamine.24 Methoxamine produced a concen-
tration-dependent contraction (Figure 1A, CONTROL). In the
presence of SNP, the methoxamine concentration-response
relationship was shifted to the right compared with the
control, demonstrating the anticontractile effect of SNP
(Figure 1A). The methoxamine concentration-response rela-
tionships were compared by their area under the curve (for
details, see Methods). Accordingly, the anticontractile
effect of SNP was quantified as the area between the
methoxamine-induced concentration-response relationships
obtained in the absence and in the presence of SNP
(Figure 1C). This analysis showed that SNP produced a
concentration-dependent shift of the methoxamine concen-
tration-response relationship to the right (Figure 1D,
CONTROL).
To study the contribution of the BK channel to the
anticontractile effect of SNP, the BK channel blocker
iberiotoxin was used at a saturating concentration,25 used
in the vast majority of studies on BK channels. In the presence
of iberiotoxin, the SNP-induced shift to the right of the
methoxamine concentration-response relationship was also
observed (Figure 1B). However, in contrast to expectation, the
anticontractile effect of SNP was greater when the BK channel
was blocked compared with when it was not blocked
(Figure 1D). More important, this unexpected finding was
reproduced by other NO donors, like S-nitroso-N-acetylpeni-
cillamine (Figure S3A) and diethylenetriamine-NO (Figure S3B).
Because of a much lower rate of NO release, diethylenetri-
amine-NO had to be used at higher concentrations compared
with the other NO donors.26 The new finding was also
reproduced with acetylcholine (Figure S3C) and its more
stable analog, carbachol (Figure S3D). As expected, the effect
of the latter was mediated by NO released from the
endothelium, because its effect was blocked completely by
the endothelial NO synthase inhibitor NG-nitro-L-arginine
(Figure S3D). A major contribution of NO to acetylcholine-
induced vasodilation has previously been shown for the vessel
studied.27,28
To examine the contribution of the BK channel to the
anticontractile effect of SNP in more detail, the functional
availability of the BK channel was determined by comparing
methoxamine-induced contractions in the absence and pres-
ence of iberiotoxin. When methoxamine-induced contractions
in the absence and presence of iberiotoxin were indistin-
guishable and, therefore, BK channels were not able to affect
the methoxamine-induced response, we considered BK chan-
nels to be functionally unavailable. However, when methox-
amine-induced contractions in the absence and presence of
iberiotoxin were different and BK channels affected the
methoxamine-induced vessel response, we considered BK
channels to be functionally available. Our data showed that
methoxamine-induced contractions in the presence of iberi-
otoxin were larger than in the absence of iberiotoxin. The
functional availability of the BK channel was quantified as the
area between the methoxamine-induced concentration-
response relationships obtained in the absence and in the
presence of iberiotoxin (Figure 2C). In the presence of SNP,
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the functional availability of the BK channel was decreased at
several SNP concentrations (Figure 2A, 2B, and 2D). This
finding was reproduced by other NO donors, like S-nitroso-N-
acetylpenicillamine (Figure S4A) and diethylenetriamine-NO
(Figure S4B), as well as by acetylcholine (Figure S4C) and its
more stable analog, carbachol (Figure S4D).
More important, similar effects were observed in the
saphenous artery of the rat: a greater anticontractile effect of
SNP in the presence of iberiotoxin (Figure S5A through S5C)
and a decreased functional availability of the BK channel in
the presence of SNP (Figure S5A, S5B, and S5D).
Moreover, similar effects were also observed in mouse tail
arteries: a greater anticontractile effect of SNP in the
presence of iberiotoxin (Figure S6A through S6C) and a
decreased functional availability of the BK channel in the
presence of SNP (Figure S6A, S6B, and S6D).
Involvement of NO in the Anticontractile Effect of
SNP
It has previously been reported that SNP can release cyanide
along with NO when in contact with vessel tissue.29 Therefore,
it was clarified whether NO or cyanide mediates the effects of
SNP previously described.
First, in the presence of theNOscavenger hydroxycobalamin30
at 103 mol/L, the anticontractile effect of SNP was abolished
Figure 1. The BK channel blocker iberiotoxin (IbTX) increases the anticontractile effect of sodium nitroprusside (SNP). A, Effect of SNP on
methoxamine (MX)-induced contractions. Vessel tension in the absence (CONTROL) and presence of increasing concentrations of SNP (SNP)
(repeated-measures ANOVA: n=6, P=0.23 for SNP 108 mol/L; *n=9, P<0.001; n=7, P<0.001; n=7, P<0.001 for SNP 107, 106, and
105 mol/L, respectively). B, Effect of SNP on MX-induced contractions in the presence of IbTX. Vessel tension in the absence (IbTX) and
presence of increasing concentrations of SNP (IbTX+SNP) (repeated-measures ANOVA: n=6, P=0.40 for SNP 108 mol/L; *n=9, P<0.001; n=7,
P<0.001; n=7, P<0.001 for SNP 107, 106, and 105 mol/L, respectively). C, The anticontractile effect of SNP represented as the area
(marked in gray) between the MX-induced concentration-response relationships obtained in the absence (CONTROL) and in the presence of SNP
(SNP). D, The anticontractile effect of SNP, quantified as described in C, in the absence (CONTROL) and presence of IbTX (2-way ANOVA for
effect of SNP: P<0.001; *2-way ANOVA control vs IbTX: P<0.001; post hoc analysis: n=9, P<0.01; n=7, P<0.05; n=7, P<0.05 for SNP 107,
106, and 105 mol/L, respectively).
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(Figure S7A and S7B), including its effect on the BK channel
(Figure S7A and S7C).
Second, pretreatment of vessels with 30 U/L rhodanese
and 1.259104 mol/L sodium thiosulfate,31 which inactivate
cyanide by transferring the sulfane sulfur from thiosulfate to
cyanide to form thiocyanide and sulphite,32 did not alter the
anticontractile effect of SNP (Figure S8A and S8B) or its effect
on the BK channel (Figure S8A and S8C).
Third, cyanide itself did not show an anticontractile effect
(Figure S9A and S9B), nor did it influence BK channel
functional availability (Figure S9A and S9C).
Finally, it has been reported that SNP can directly interact
with H2S, leading to the generation of nitroxyl, and that the
latter could be responsible for the observed functional
effects.33 Pretreatment of vessels with 39103 mol/L b-
cyano-L-alanine, an inhibitor34 of the major H2S-generating
enzymes cystathionine c-lyase and cystathionine b-synthase in
vascular tissue,35 somewhat reduced the anticontractile effect
of SNP (Figure S10A and S10B). Yet, in the presence b-cyano-L-
alanine, the anticontractile effect of SNP was greater when the
BK channel was blocked, compared with when it was not
blocked (Figure S10B), and functional availability of the BK
channel was decreased in the presence of SNP (Figure S10C).
Guanylyl Cyclase and PKG Pathway in the
Anticontractile Effect of SNP
It has previously been reported that SNP induces an increase
of cGMP.36 This suggests that SNP activates the guanylyl
cyclase/PKG pathway. Application of the selective guanylyl
Figure 2. Sodium nitroprusside (SNP) decreases the functional availability of the BK channel. Effect of SNP and iberiotoxin (IbTX) on
methoxamine (MX)–induced contractions. Vessel tension in the absence of IbTX and SNP (CONTROL), in the presence of IbTX alone (IbTX), in the
presence of SNP alone (SNP), and in the combined presence of IbTX and SNP (IbTX+SNP) at, for example, 107 mol/L (A) and 105 mol/L (B)
SNP. C, The functional availability of the BK channel represented as the area (marked in gray) between the MX-induced concentration-response
relationships obtained in the absence (CONTROL) and in the presence of IbTX (IbTX) (*repeated-measures ANOVA: n=9; P<0.001). D, Functional
availability of the BK channel, quantified as described in C, in the absence (CONTROL) and presence of SNP (SNP) (t test: n=6, P=0.91; *n=9,
P<0.001; n=7, P<0.01; n=7, P<0.01 for SNP 108, 107, 106, and 105 mol/L, respectively).
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cyclase blocker 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one37
at 106 mol/L abolished the anticontractile effect of SNP
(Figure 3A and 3B) and its effect on the BK channel
completely (Figure 3A and 3C). In the presence of
105 mol/L Rp-8-Br-PET-cGMPS, a selective PKG inhibitor,38
the anticontractile effect of SNP (Figure 3D and 3E) and its
effect on the BK channel (Figure 3D and 3F) were reduced.
Involvement of Changes in the [Ca2+]i in the
Anticontractile Effect of SNP
Because the [Ca2+]i is a major regulator of BK channel activity,
the effect of SNP on [Ca2+]i was studied.
In the presence of SNP, the methoxamine concentration-
response relationship for [Ca2+]i was shifted to the right,
compared with the control (Figure 4A), similar to the effect of
SNP onmethoxamine-induced tension (as previously described).
In the presence of iberiotoxin, the SNP-induced shift to the
right of the methoxamine concentration-response relationship
for [Ca2+]i was also observed (Figure 4B). The effects of SNP
on [Ca2+]i were greater when the BK channel was blocked,
compared with when it was not blocked.
Involvement of Changes in Calcium Release and
Calcium Influx in the Anticontractile Effect of SNP
The attenuation of themethoxamine-induced increase in [Ca2+]i
by SNP may result from an interference of SNP with the
methoxamine-evoked release of calcium from intracellular
stores mediated by ryanodine receptors and/or IP3 receptors.
Figure 3. Effect of the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and the protein kinase G
inhibitor Rp-8-Br-PET-cGMPS (Rp) on the anticontractile effect of sodiumnitroprusside (SNP). A, Effect of SNPand iberiotoxin (IbTX)
onmethoxamine (MX)–inducedcontractions in the presenceof ODQ (106 mol/L). Vessel tension in the absenceof IbTX and SNP
(CONTROL), in thepresenceof IbTXalone (IbTX), in thepresenceof SNPalone (SNP), and in thecombinedpresenceof IbTXandSNP
(IbTX+SNP) at 107 mol/L SNP (repeated-measures ANOVA: n=5, P=0.71 for CONTROL vs SNP and n=5, P=0.85 for IbTX vs
IbTX+SNP). B, The anticontractile effect of SNP in the absence (CONTROL) and presence of IbTX (t test: n=5,P=0.38). C, Functional
availability of the BKchannel in the absence (CONTROL) and presence of SNP (SNP) (t test: n=5, P=0.53). D, Effect of SNP and IbTX
onMX-induced contractions in the presence of 105 mol/L Rp. Vessel tension in the absence of IbTX and SNP (CONTROL), in the
presence of IbTX alone (IbTX), in the presence of SNP alone (SNP), and in the combined presence of IbTX and SNP (IbTX+SNP) at
107 mol/L SNP (repeated-measures ANOVA: n=8, P<0.01 for CONTROL vs SNP and n=8, P<0.001 for IbTX vs IbTX+SNP). E, The
anticontractile effect of SNP in the absence (CONT) andpresenceof IbTX (*2-wayANOVAwithout [w/o] vswithRp: n=8;P<0.001; t
test CONTvs IbTX:w/oRpn=8;P<0.001;withRp n=8;P<0.001). F, Functional availability of theBKchannel in the absence (CONT)
and presence of SNP (SNP) (*t test w/o vswith Rp: n=8; P<0.05; t test CONT vs SNP: w/oRp n=8; P<0.001; with Rp n=8; P<0.01).
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However, the increase in [Ca2+]i produced by 10
2 mol/L
caffeine, a widely used and selective activator of ryanodine
receptors, was not altered by SNP (Figure 5A). Furthermore,
when calcium influx was eliminated by adding 39103 mol/L of
the calcium chelator EGTA to the extracellular solution shortly
before application of methoxamine, the increase in [Ca2+]i
induced by 105 mol/L methoxamine was not affected by SNP
(Figure 5B). Moreover, [Ca2+]i store content was estimated by
applying the calcium-ionophore ionomycin in the presence of
EGTA in the extracellular solution (for more detail, see
Methods).23 The increase in [Ca2+]i produced by 10
5 mol/L
ionomycin was also not altered by SNP (Figure 5C). In contrast,
when calcium release was eliminated by pretreating vessels with
the widely used sarco/endoplasmic reticulum Ca2+-ATPase
inhibitor, cyclopiazonic acid, at 105 mol/L and the ryanodine
receptor blocker, ryanodine, at 105 mol/L to leave only
calcium influx, the methoxamine-induced increase in [Ca2+]i
was shifted to the right in the presence of SNP (Figure 5D).
Notably, under these conditions, the methoxamine-induced
increase in [Ca2+]i was prevented completely by vessel pretreat-
ment with 106 mol/L nimodipine, an established blocker of L-
type voltage-dependent calcium channels (VOCs) (Figure 5D).
Involvement of Changes in Calcium Influx in the
Anticontractile Effect of SNP
The reduction of calcium influx via VOCs by SNP may result
from an SNP-induced opening of non-BK potassium chan-
nels,39 leading to cell membrane hyperpolarization and a
subsequent closure of VOCs. However, when most non-BK
potassium channels known to be expressed in vascular
smooth muscle were inhibited by a blocker mixture (which
contained the Kv1 channel blocker diphenyl phosphine oxide-
1 at 106 mol/L,40 the Kv2 channel blocker stromatoxin at
107 mol/L,41 the Kv7 channel blocker XE991 at
39106 mol/L,42 the Kir2 channel blocker barium chloride
at 39105 mol/L,43 and the Kir6 channel blocker gliben-
clamide at 106 mol/L44), a greater anticontractile effect of
SNP in the presence of iberiotoxin (Figure S11A and S11B)
and a decreased functional availability of the BK channel in
the presence of SNP (Figure S11A and S11C) were still
observed. When the indirect potassium channel–mediated
effects of SNP on VOC were eliminated by either precon-
tracting vessels with 120 mmol/L KCl or applying the
previously mentioned blocker mixture, including 107 mol/L
iberiotoxin, SNP produced relaxation (Figure S11D) associated
with a decrease in [Ca2+]i (Figure S11E).
Finally, in tail arteries of BK channel b1-subunit–deficient
mice,17 SNP produced an anticontractile effect (Figure 6A
through 6C), but this effect was not augmented anymore in
the presence of iberiotoxin (Figure 6A through 6C), and SNP
had no effect on the functional availability of the BK channel
(Figure 6A, 6B, and 6D).
Discussion
The present study revealed 8 major findings. First, contin-
uously present NO donors (SNP, S-nitroso-N-acetylpenicilla-
mine, and diethylenetriamine-NO), and endogenously
produced NO, released in response to acetylcholine and
carbachol, evoke an anticontractile effect. Second, these
substances produce a greater anticontractile effect in the
Figure 4. The BK channel blocker IBTX increases the effect of SNP on intracellular calcium. A) Effect of SNP on MX-induced [Ca2+]i
increase. F340/F380 ratio, a measure for the intracellular calcium concentration, in the absence (CONTROL) and presence of SNP (SNP
107 M) (* - repeated measures ANOVA: n=5, P<0.05). B) Effect of SNP on MX-induced [Ca2+]i increase in the presence of IbTX. F340/
F380 ratio in the absence (IbTX) and presence of SNP (IbTX+SNP 107 M) (* - repeated measures ANOVA: n=8, P<0.001). The effect of
SNP on MX-induced [Ca2+]i increases was larger in the presence of IbTX compared to its absence (t-test: n=5,8; P<0.05).
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presence of iberiotoxin, and decrease the functional avail-
ability of the BK channel. Third, these 2 effects occur in
several arteries from rats and mice. Fourth, the observed
effects of SNP were not mimicked by cyanide and not
altered by rhodanese together with sodium thiosulfate, nor
by b-cyano-L-alanine. Fifth, the effects were abolished by
hydroxycobalamin and by 1H-[1,2,4]oxadiazolo[4,3-a]quinox-
alin-1-one, and reduced considerably by Rp-8-Br-PET-cGMPS.
Sixth, SNP reduced the [Ca2+]i response to methoxamine in
vascular smooth muscle cells. Seventh, SNP did not alter the
[Ca2+]i response to caffeine and to methoxamine and
ionomycin in calcium-free extracellular solution. Eighth,
SNP reduced the [Ca2+]i response to methoxamine when
calcium release was eliminated: a response depending
entirely on VOCs.
Anticontractile Effect of NO Donors Is Mediated
by NO
NO is a gas that is difficult to handle. Therefore, in almost all
experimental studies, as well as in clinical practice,45,46 NO
donors are used. However, NO donors may evoke their
effects, at least partly, independently of NO.45,46 Yet, this
seems not to be the case in the present study.
First, 3 different NO donors, SNP, S-nitroso-N-acetylpeni-
cillamine, and diethylenetriamine-NO, possessing different
properties, except the ability to release NO, produced
identical effects. Moreover, the same effects were evoked
by acetylcholine and carbachol, known to release endogenous
NO from vascular endothelium.27,28 This was also observed in
the present study, where their effects were blocked by NG-
Figure 5. Sodium nitroprusside (SNP) affects intracellular calcium concentration ([Ca]i) by an interaction
with calcium influx. A, Effect of SNP on caffeine-induced [Ca]i increase. F340/F380 ratio in the absence
(CONTROL) and presence of SNP (SNP 107 mol/L) (t test: n=5, P=0.76). B, Effect of SNP on
methoxamine (MX)–induced [Ca]i increase in calcium-free extracellular solution. F340/F380 ratio in the
absence (CONTROL) and presence of SNP (SNP 107 mol/L) (t test: n=5, P=0.73). C, Effect of SNP on
ionomycin-induced [Ca]i increase in calcium-free extracellular solution. F340/F380 ratio in the absence
(CONTROL) and presence of SNP (SNP 107 mol/L) (t test: n=5, P=0.71). D, Effect of SNP or nimodipine
on MX-induced [Ca]i increase in the presence of 10
5 mol/L cyclopiazonic acid (CPA) and 105 mol/L
ryanodine. F340/F380 ratio in the absence (CONTROL) and presence of SNP (SNP 107 mol/L) or
nimodipine (106 mol/L) (*repeated-measures ANOVA: n=6, P<0.001 and n=5, P<0.001, respectively).
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nitro-L-arginine, an established endothelial NO synthase
inhibitor.
Second, the presented data show that the effects of the
most often used NO donor in this study (SNP) were abolished
by hydroxycobalamin, an NO scavenger.30 Also, its effects
were not mimicked by cyanide, previously reported to be
released from SNP along with NO.29 Furthermore, the effects
were not affected by rhodanese and sodium thiosulfate,31
which inactivate cyanide.32 Finally, the effects of SNP were
also unaltered by b-cyano-L-alanine, an inhibitor34 of cys-
tathionine c-lyase and cystathionine b-synthase, the major
H2S-producing enzymes in vascular tissue.
35 H2S has been
reported to interact directly with SNP, leading to the
generation of nitroxyl responsible for the functional observed
effects.33
Third, in line with the established opinion that the vasodila-
tory effect of NO is mediated by the soluble guanylyl cyclase/
PKG signaling pathway,3,4 the effects of SNP observed in the
present study were as follows: (1) abolished by the selective
soluble guanylyl cyclase blocker 1H-[1,2,4]oxadiazolo[4,3-a]
quinoxalin-1-one37 and (2) reduced by the selective PKG
inhibitor, Rp-8-Br-PET-cGMPS.38 Rp-8-Br-PET-cGMPS at con-
centrations higher than the one used in the present study may
stimulate basal PKG activity.47,48 Consequently, such Rp-8-Br-
PET-cGMPS concentrations were not used, even if they may be
required for the complete inhibition of PKG.47,48
Figure 6. Contribution of the BK channel to the anticontractile effect of sodium nitroprusside (SNP) in tail arteries of b1-deficient mice.
Effect of SNP and iberiotoxin (IbTX) on methoxamine-induced contractions. Vessel tension in the absence of IbTX and SNP (CONTROL), in the
presence of IbTX alone (IbTX), in the presence of SNP alone (SNP), and in the combined presence of IbTX and SNP (IbTX+SNP) at 107 mol/L
(A) and 106 mol/L (B) SNP. C, The anticontractile effect of SNP in the absence (CONTROL) and presence of IbTX (2-way ANOVA for effect of
SNP: n=8; P<0.001; 2-way ANOVA control vs IbTX: n=8; P=0.92). D, Functional availability of the BK channel in the absence (CONTROL) and
presence of SNP (SNP) (t test: n=8, P=0.85 and n=8, P=0.98 for SNP 107 and 106 mol/L, respectively).
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In conclusion, several lines of evidence provided in the
present study strongly suggest that the effects observed
using NO donors are induced by NO.
BK Channel Limits the Anticontractile Effect of
NO
The data of the present study show that NO produces a
concentration-dependent shift of the methoxamine concen-
tration-response relationship to the right, which equals an
anticontractile effect. Many previous investigations reported
that NO produces vasodilation.3 This strongly supports our
findings demonstrating an anticontractile effect of NO.
However, our observations about the contribution of the
BK channel to the anticontractile effect of NO were
completely unexpected. Previously, a substantial number of
studies provided evidence that BK channels mediate NO-
induced vasodilation8–11 (additional studies listed and dis-
cussed by Tanaka et al12). A few studies reported that BK
channels do not contribute to NO-induced vasodilation.13–16
The data of the present study show that the anticontractile
effect of NO was greater when the BK channel was blocked. In
addition, we observed that the functional availability of the BK
channel was decreased in the presence of NO. Most
important, these findings were observed on 2 different vessel
preparations in 2 species, the rat and the mouse. Thus, the
data of the present study suggest the new alternative idea
that BK channels can limit the anticontractile effect of NO.
An alternative analysis of the data provided more insight.
This analysis showed that the SNP-induced relaxation is
smaller in the presence of iberiotoxin (Figure S12), suggesting
that BK channels facilitate NO-induced vasodilation. There is
an important limitation with this alternative approach. With
this approach, the effect of NO is studied on the basis of a
single initial contractile state at a high contraction level.
There, NO produced only a small decrease in [Ca2+]i
(Figure 4B at 106 mol/L methoxamine). In contrast, in the
present study, vessels were contracted from full relaxation to
maximal contraction, and the effect of NO was investigated on
the basis of the full range of vessel contractility. There, NO
generated a considerable decrease in [Ca2+]i (Figure 4B).
Thus, the difference in the effect of NO on [Ca2+]i may be the
reason for obtaining 2 contradictory conclusions.
The latter idea is emphasized by the following mechanistic
considerations. At a high contraction level, NO induces a PKG-
mediated increase in BK channel activity, well established by
many studies,1,5,6 that is stronger than the small [Ca2+]i
decrease–mediated decrease of BK channel activity. The
overall effect of both is an activation of the BK channel,
consistent with the conclusion reached with the alternative
approach that BK channels facilitate NO-induced vasodilation
(Figure 7A). With the approach of the present study,
especially at lower levels of contractility, NO induces a PKG-
mediated increase in BK channel activity that is weaker than
the large [Ca2+]i decrease–mediated decrease in BK channel
activity. The overall effect of both is a reduction of BK channel
activity, consistent with the conclusion reached in this study:
that BK channels limit the anticontractile effect of NO
(Figure 7B). Thus, the effect of NO on the BK channel seems
to be mediated by a signaling pathway consisting of 2
simultaneously activated branches: 1 increasing and 1
decreasing BK channel activity, where a decrease in channel
activity prevails when the full range of vessel contractility is
considered. Because a high contraction level was used in
most previous studies, the role of a decrease in [Ca2+]i for BK
channel functional availability during NO-induced vasodilation
was underestimated. Thus, the existence of opposing conclu-
sions reached in this and in previous studies is not
contradictory, but rather reflects a common mechanism
explored at different conditions as related to the level of
preconstriction used.
In conclusion, the data of the present study promote the
new idea that the BK channel limits the anticontractile effect
of NO, especially at lower levels of contractility, where NO
induces a strong decrease of [Ca2+]i (Figure 7B). Only at high
contraction levels, where NO induces a small decrease of
[Ca2+]i, does the BK channel facilitate NO-induced vasodila-
tion (Figure 7A).
Figure 7. Schematic representation of the mechanism of BK
channel contribution to the anticontractile effect of sodium
nitroprusside. A, Conditions when NO produced only a small
decrease in intracellular calcium concentration ([Ca2+]i): NO
induces a protein kinase G (PKG)–mediated activation of the BK
channel that is stronger than the small [Ca2+]i decrease–mediated
deactivation of the BK channel. The overall effect of both is an
activation of the BK channel contributing to the reduction of
calcium influx; BK channels facilitate NO-induced vasodilation. B,
Conditions when NO produced a considerable decrease in [Ca2+]i:
NO induces a PKG-mediated activation of the BK channel that is
weaker than the large [Ca2+]i decrease–mediated deactivation of
the BK channel. The overall effect of both is a deactivation of the
BK channel opposing the reduction of calcium influx; BK channels
limit NO-induced vasodilation.
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Ability of the BK Channel to Limit the
Anticontractile Effect of NO Is Caused by an NO-
Induced Reduction of Calcium Influx via L-Type
Calcium Channels
In the present study, NO reduced the methoxamine-induced
increase in [Ca2+]i. This observation is supported by many
findings published previously49,50 (reviewed by Francis et al4).
However, an unexpected increase of the effect of NO on
[Ca2+]i was observed when BK channels were blocked. This is
an important finding. Indeed, if BK channels were to facilitate
NO-evoked dilations, as often suggested, the NO-induced
activation of BK channels would lead to membrane potential
hyperpolarization, a closure of VOCs, and a subsequent
decrease of [Ca2+]i. This mechanism would be suppressed in
the presence of BK channel blockers like iberiotoxin, reflected
by a smaller NO-induced decrease of [Ca2+]i in the presence
of iberiotoxin. More important, just the opposite was observed
in the presence of iberiotoxin: a larger decrease of [Ca2+]i in
response to NO was seen. Thus, these data mechanistically
support the newly suggested limiting role of the BK channel
on NO-induced vasodilation.
In addition, the data of the present study suggest a
mechanism by which NO produces the decrease in [Ca2+]i.
First, NO did not affect increases in [Ca2+]i produced by
caffeine. Neither did it affect the increases in [Ca2+]i caused
by methoxamine, when calcium influx was eliminated by
adding EGTA to the extracellular solution shortly before
application of methoxamine. And NO also did not affect the
increases in [Ca2+]i caused by ionomycin in the presence of
EGTA in the extracellular solution, providing an estimate of
[Ca2+]i store content (for more details, see Methods and the
study by Fasolato and Pozzan23). Thus, NO does not seem to
interfere with calcium release from and calcium sequestration
into [Ca2+]i stores.
Second, on depleting [Ca2+]i stores and inhibiting calcium-
induced calcium release from these stores by pretreating
vessels with cyclopiazonic acid and ryanodine, NO still reduced
the increase in [Ca2+]i produced by methoxamine. Because the
methoxamine-induced increase in [Ca2+]i under these condi-
tions was completely abolished by nimodipine, it can be
concluded that this calcium influx was exclusively mediated by
VOCs. Thus, NO decreases [Ca2+]i by a reduction of calcium
influx via VOCs, a mechanism discussed previously.4
Third, for the reduction of VOC activity by NO, it should be
considered that NO could produce this effect indirectly,
mediated by cell membrane hyperpolarization in response to
an NO-induced opening of non-BK potassium channels, as
observed previously.39 However, the anticontractile effect of
NO and its action on the functional availability of the BK
channel were not altered when most non-BK potassium
channels known to be expressed in vascular smooth muscle
were inhibited by a blocker mixture (containing the Kv1
channel blocker diphenyl phosphine oxide-1,40 the Kv2
channel blocker stromatoxin,41 the Kv7 channel blocker
XE991,42 the Kir2 channel blocker barium chloride,43 and the
Kir6 channel blocker glibenclamide44). In addition, NO
produced considerable decreases in [Ca2+]i when potassium
channels, including BK channels, were either functionally
silenced by precontracting vessels with 120 mmol/L KCl or
inhibited by the previously mentioned blocker mixture includ-
ing iberiotoxin. These experimental conditions eliminate
indirect potassium channel–mediated effects of NO on VOCs.
Thus, NO reduces VOC activity by a mechanism independent
of changes in membrane potential in response to an NO-
induced activation of non-BK potassium channels. This
mechanism most likely involves soluble guanylyl cyclase and
PKG, according to the data presented in this study and to
previous findings showing a PKG-induced inhibition of L-type
VOCs in isolated vascular smooth muscle cells.51,52 The
details of this mechanism are beyond the focus of the present
study and have to be addressed in future studies.
Finally, this study provides another important piece of
evidence supporting the idea that an NO-induced reduction of
calcium influx via VOC enables the BK channel to limit the
anticontractile effect of NO. Namely, in BK channel b1-
subunit–deficient mice, in which the BK channel cannot
respond to NO-induced reductions of calcium influx because
of a considerably decreased calcium sensitivity of the BK
channel,17 the anticontractile effect of NO, and its action on
the functional availability of the BK channel were no longer
affected by iberiotoxin.
In conclusion, the data of the present study show that anNO-
induced reduction of calcium influx via L-type VOCs leads to a
decrease of BK channel activity, which limits the anticontractile
effect of NO, especially at lower levels of contractility.
This study demonstrates, first, that continuously present NO
donors evoke a strong anticontractile effect on rat and mouse
arteries, which is induced by NO. Second, it shows that the
iberiotoxin-induced augmentation of the anticontractile effect of
NO is associated with an NO-induced reduction of the effect of
iberiotoxin over almost the whole range of vessel contractility,
whereas activation of BK channels facilitates NO-induced
vasodilation only at high contraction levels. Finally, it reveals
that NO evokes a reduction of calcium influx via L-type calcium
channels that may enable the BK channel to limit the anticon-
tractile effect of NO, especially at lower levels of contractility.
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